Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Roshan Prajapati

Bhaktapur Cancer Hospital, Nepal

Title: Ovarian cancer: Single Institutional based data

Biography

Biography: Roshan Prajapati

Abstract

Background: Ovarian cancer oft en has no symptoms at the early stages, so the disease is generally advanced when it is
diagnosed. Ovarian cancer is the seventh most common cancer in women worldwide and 18 most common cancer overall.
Epithelial ovarian cancer (EOC) is the leading cause of death in women with gynecological malignancy. Due to inadequate
screening tools and a lack of early clinical symptoms, approximately 70% of women with EOC are diagnosed with advanced
stage of disease, which is associated with high morbidity and mortality.
Methods: All detailed data of ovarian carcinoma taken from hospital registry of 2017.
Result: Ovarian carcinoma is the 13th common cancer in Bhaktapur Cancer Hospital and second most common gynaecological
cancer aft er cervical carcinoma. It consists of 2.3% of all cancer in 2017. Out of which 40% were referred from other centres
for adjuvant chemotherapy and palliative chemotherapy. 60% had undergone surgery in Bhaktapur Cancer Hospital. Medium
age is 49 years (22-75). 10% had borderline tumours, 15% had mucinous cystadenocarcinoma and 51% had high grade serous
adenocarcinoma. 55% has received neo adjuvant chemotherapy followed by interval cytoreductive surgery.
Conclusion: Ovarian carcinoma has been found to be a second leading gynaecological malignancy. Patient usually presented
in advanced disease. Most common histopathological fi nding is high grade serous adenocarcinoma.